Delivery Order SPE2DB24D2101-SPE2DB25FKNBW
- Not listed
- The Defense Logistics Agency awarded a $9,266.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Tavalisse 100 mg tablets (60-count units). This is a non-set-aside contract with a completion date of July 31, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $9,296.97 to AmerisourceBergen Drug Corp for the supply of Tavalisse 150 mg tablets (60-count) on August 15, 2025, with a completion date of September 8, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Tavalisse 100 mg tablets (60-count units) with a ceiling value of $18,533.40. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among all eligible...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Tavalisse 100 mg tablets (60-count units) with a ceiling value of $9,266.70. This firm fixed-price delivery order, due for completion by September 23, 2025, represents a non-set-aside competitive award to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a $9,296.97 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Tavalisse 150 mg, a pharmaceutical product delivered to the company's corporate office location in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency awarded a $9,266.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Tavalisse 100 mg tablets (60-count units) on April 24, 2025, with an ultimate completion date of May 15, 2025. This non-competitive delivery order is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Tavalisse 100 mg tablets (60-count units) with a contract ceiling value of $9,266.70. This firm fixed-price delivery order, which is not set-aside and competitively awarded, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 10, 2025, for Tavalisse 150 mg tablets (60-count packaging) with a ceiling value of $37,127.34. This competitively awarded, firm fixed-price delivery order is non-set-aside and scheduled for completion by October 1, 2025. The award represents a continuation of the contractor's substantial role in supporting...
- The Defense Logistics Agency awarded a delivery order valued at $9,296.97 to AmerisourceBergen Drug Corp for Tavalisse 150 mg tablets (60-count) on September 3, 2025, with completion expected by September 24, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Tavalisse is a prescription medication used to treat immune thrombocytopenia, a bleeding disorder affecting...
- This is a delivery order under a larger contract vehicle awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The delivery order is for $8,549.70 to provide Tavalisse 150 mg tablets. The order has a firm fixed price and a completion date of September 26, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, as well as a...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKNBWDelivery Order
The Defense Logistics Agency awarded a $9,266.70 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Tavalisse 100 mg on August 5, 2025, with completion targeted for August 26, 2025. This competitively awarded, firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order falls within AmerisourceBergen's comprehensive pharmaceutical supply portfolio delivered through the DLA Medical Supply Chain. The company's $999 million prime indefinite delivery vehicle enables flexible procurement of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency customers, U.S. Coast Guard, and other government healthcare systems globally. The award reflects AmerisourceBergen's established capability to meet federal procurement requirements through competitive processes, consistent with its extensive track record of delivering both brand-name and generic pharmaceuticals to military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.3k | 8/5/25 |